5%
Original price was: $210.00.$199.00Current price is: $199.00.
Retatrutide is a triple agonist targeting GLP-1, GIP and glucagon receptors, developed for the management of obesity and significant weight reduction. Administered by subcutaneous injection, it combines anorexigenic effects, improved insulin sensitivity and increased energy metabolism. Clinical trials have shown marked weight losses greater than those observed with current treatments,positioning retatrutide as a promising option for the medical management of obesity.
⚠️Important note
Each product must be mixed with bacteriostatic water. A Free 3ml bottle is included with every purchase.
Description
Retatrutide is a triple agonist targeting GLP-1, GIP and glucagon receptors, developed for the management of obesity and significant weight reduction. Administered by subcutaneous injection, it combines anorexigenic effects, improved insulin sensitivity and increased energy metabolism. Clinical trials have shown marked weight losses greater than those observed with current treatments,positioning retatrutide as a promising option for the medical management of obesity.
Key features:
- Mechanism: dual GIP/GLP-1 agonist
- Route: weekly subcutaneous injection
- Presentation: injectable formulations
- Expected effects: improvement of blood sugar levels, fat loss, reduction of
appetite
Customer benefits:
- Better glycemic control and reduction of HbA1c
- Clinical and sustainable weight loss under medical supervision
- Convenient weekly administration schedule
Storage
| Before reconstitution: | After reconstitution: |
|---|---|
| -Temperature: generally -20°C (frozen) -Protect from light and moisture; keep vial tightly closed -Avoid repeated freeze/thaw cycles | -Temperature: usually 2-8 °C, protected from light -Do not freeze the reconstituted solution |
2 reviews for Tirzepatide 30 MG
There are no reviews yet.